Reductive alkylation of glycopeptide antibiotics
CA 2272240 C · Owner: Berglund, Richard Alan · Inventors: Magadanz, Howard Eugene; Berglund, Richard Alan; Zheng, Hua
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is concerned with improved processes for reductive alkylation of glycopeptide antibiotics. The improvement residing in providing a source of copper which results in the initial production of a copper complex of the glycopeptide antibiotic. Reductive alkylation of this complex favors regioselective alkylation and increased yields. Copper complexes of the glycopeptide antibiotic starting materials and of the alkylated products are also part of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 1997 and granted February 8, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 20, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.